NDC11 70377009211
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 70377-0092-11 | 70377-0092 |
| 70377-092-11 | 70377-092 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Everolimus | EVEROLIMUS | Biocon Pharma Inc. | 5b809dfe-c076-07c5-207e-178c3f0d32d3 | 2026-06-30 | Warnings, Adverse reactions | 70377-092-11 70377-092 70377009211 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.